Meritage Portfolio Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$727K	Sell	20,902 -2,505	-11%	-$197K	0.05%	196
2025 Q3	$1.95M	Sell	23,407 -11,832	-34%	-$856K	0.13%	162
2025 Q2	$2.59M	Sell	35,239 -1,200	-3%	-$87K	0.16%	147
2025 Q1	$4.16M	Buy	36,439 +6,628	+22%	+$403K	0.28%	108
2024 Q4	$1.5M	Buy	29,811 +2,783	+10%	+$146K	0.09%	175
2024 Q3	$1.25M	Buy	27,028 +2,459	+10%	+$87.4K	0.08%	189
2024 Q2	$798K	Buy	24,569 +119	+0.5%	+$3.26K	0.05%	213
2024 Q1	$616K	Sell	24,450 -1,818	-7%	-$43K	0.04%	228
2023 Q4	$853K	Buy	26,268 +949	+4%	+$26.1K	0.06%	210
2023 Q3	$690K	Buy	25,319 +146	+0.6%	+$4.23K	0.05%	214
2023 Q2	$560K	Buy	25,173 +5,585	+29%	+$129K	0.04%	230
2023 Q1	$424K	Sell	19,588 -74	-0.4%	-$1.62K	0.03%	223
2022 Q4	$399K	Buy	19,662 +607	+3%	+$15.2K	0.03%	227
2022 Q3	$489K	Buy	19,055 +633	+3%	+$16.9K	0.04%	212
2022 Q2	$438K	Sell	18,422 -456	-2%	-$9.94K	0.03%	222
2022 Q1	$425K	Buy	18,878 +8,378	+80%	+$178K	0.03%	231
2021 Q4	$208K	Buy	+10,500	New	+$213K	0.01%	325